[1]
R. Ravasio and A. Migliore, “Economic evaluation of low-dose SKA cytokines in patients with rheumatoid arthritis in maintaining low disease activity or remission”, AboutOpen, vol. 7, no. 1, pp. 67–73, Sep. 2020.